Wharton Jelly Log inProvider access

Wharton Jelly

The premier biologic for precision medicine.

Individualized precision medicine is the future of health care.

For doctors & providers For consumers & patients

Two paths. Pick yours.

Clinicians integrating biologics into practice need protocols, training and supply. Patients need to understand their options and find a provider near them.

Clinicians

Provider program

Advanced support, documentation, protocols and product access — plus our central education and clinical support hub.

Provider access →

Patients

Understand your options

What these products are, what they are not, and the questions worth asking before you decide.

Patient information →

Education

Institute of Regenerative Education

Empowering the Next Generation of Regenerative Medicine Leaders

Explore →

Clinical education, not marketing hype

Our education partner is the Institute of Regenerative Education. Advancing Education & Research in Biologics.

Clinical education

How do we talk to patients about “Stem Cells”?

When presenting human cell and tissue products (HCTPs) to patients, providers should avoid unregulated terms like “stem cells” and instead focus on ti…

Clinical education

Regulatory Environment Around Stem Cells — Dispelling Myths

Dr. Martin delivers a critical and detailed overview of the U.S. regulatory landscape surrounding stem cells, emphasizing that using the term “stem ce…

Clinical education

Are Stem Cells a Scam?

Dr. Martin addresses the misconception that “stem cells” are a cure-all, emphasizing that successful regenerative outcomes depend not on magical produ…

🔒

Clinical modules, protocols and documentation are available to registered providers.

Create your free account

Doctors — join the referral network

Doctors Join Now
Important: This content is provided for educational purposes and research use only (RUO). It reflects the professional experience and academic perspectives of credentialed providers and is not intended to diagnose, treat, cure, or prevent any disease. Clinical application and regulatory compliance remain the responsibility of the licensed provider.